Clinical trials sponsored by Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic

Phase breakdown

Conditions studied

Recruiting trials led by Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic

• Fractionated Stereotactic Radiotherapy Plus Second-generation Antiandrogen for Oligometastatic Castration-resistant Prostate Cancer Patients.
  NCT07717268 · Phase: Phase 2 · Ages: No age limits stated · Sex: Male · 15 locations
• START-MET HS Prostate Cancer. : SbrT & Androgen Receptor Therapy METastatic HSPC
  NCT05209243 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: Male · 2 locations
• Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624
  NCT05781217 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 17 locations

Common questions

How many trials is Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic recruiting for?

Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic is the lead sponsor of 3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.